Health ❯ Healthcare ❯ Regulatory Approval

FDA Approval

Epcoritamab Approval Drug Indications Medical Devices Blenrep Approval

FDA Clears GSK’s Exdensur as First Twice-Yearly Add-On for Severe Eosinophilic Asthma

The long-acting IL-5 antibody targets eosinophilic disease with a dosing schedule GSK says could improve adherence.

Epcoritamab Added to R2 Yields Large Efficacy Gains in Relapsed Follicular Lymphoma

FDA Reapproves GSK’s Blenrep for Multiple Myeloma in Narrow Combination Use